S 4472 · 119th Congress
Accelerating Access to Critical Therapies for ALS Reauthorization Act of 2026
This bill extends a federal program that helps speed up the development and approval of treatments for ALS (amyotrophic lateral sclerosis), a serious neurodegenerative disease. Right now, the program is set to expire in 2026, but this bill would keep it running through 2031, giving researchers and drug companies fiv…
- Sponsor
- Murkowski, Lisa (R-Alaska)
- Introduced
- 2026-04-30
- Policy area
- Health
- Latest action
- Passed Senate with an amendment by Voice Vote. (consideration: CR S4425-4426; text: CR S4425-4426)
Digging through Congress... 🔍